Cargando…
Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents
A conformational restriction strategy was used to design and synthesize nine TZT-1027 analogues. 3-Aryl-azetidine moiety was used to replace phenylethyl group of TZT-1027 at the C-terminus. These analogues exhibited moderate to excellent antiproliferative activities, and the most potent compound 1a...
Autores principales: | Yan, Qi, Wang, Yujie, Zhang, Wei, Li, Yingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882559/ https://www.ncbi.nlm.nih.gov/pubmed/27136567 http://dx.doi.org/10.3390/md14050085 |
Ejemplares similares
-
Characterization of the Interaction of TZT‐1027, a Potent Antitumor Agent, with Tubulin
por: Natsume, Tsugitaka, et al.
Publicado: (2000) -
Antitumor Activity of TZT‐1027, a Novel Doiastatin 10 Derivative
por: Kobayashi, Motohiro, et al.
Publicado: (1997) -
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
por: Akashi, Y, et al.
Publicado: (2007) -
TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
por: Otani, Masashi, et al.
Publicado: (2000) -
Manipulation of pathway regulation in Streptomyces globisporus for overproduction of the enediyne antitumor antibiotic C-1027
por: Chen, Yihua, et al.
Publicado: (2010)